A randomized clinical trial of home nursing care for lung cancer patients

McCorkle, Ruth; Benoliel, Jeanne Quint; Donaldson, Gary; Georgiadou, Fotini; Moinpour, Carol M.; Goodell, Brian W.

doi:10.1002/1097-0142(19890915)64:6<1375::aid-cncr2820640634>3.0.co;2-6

Cited by 238 publications

(233 citation statements)

References 20 publications

Supporting

Mentioning

207

Contrasting

Unclassified

Order By: Relevance

“…For the current study, the 15-item Symptom Distress Scale was used to index the degree of problems the patient had with treatment side effects. 70,71 Symptom distress yielded two scores: the total number of symptoms reported and the average intensity of the symptoms reported on a 1 to 5 scale. Scores were reversed so that higher scores reflected more improvement in the symptom.…”

Section: Dependent Measuresmentioning

confidence: 99%

Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects

Mishel

Belyea

Germino

et al. 2002

Cancer

195

310

View full text Add to dashboard Cite

BACKGROUNDThe objective of this study was to test the efficacy of an individualized uncertainty management intervention delivered by telephone to Caucasian and African‐American men with localized prostate carcinoma and directed at managing the uncertainties of their disease and treatment.METHODSThe authors delivered a psychoeducational intervention by phone to men with prostate carcinoma, with or without supplemented delivery to a close family member, that was directed at managing uncertainty and improving symptom control. One hundred thirty‐four Caucasian men and 105 African‐American men were assigned randomly to one of two approaches to delivering the intervention or to the control condition. Men entered the study immediately after surgical treatment or in the first 3 weeks of radiation therapy. Trained nurses delivered the intervention through weekly phone calls for 8 weeks.RESULTSThe authors found that the majority of intervention effects were from baseline to 4 months postbaseline, when treatment side effects are most intense. Both Caucasian men and African‐American men who received either one of the two approaches for delivering the intervention improved in the two uncertainty management methods of cognitive reframing and problem solving. Similarly, when the intervention groups were combined, men who received the intervention also improved significantly in control of incontinence by 4 months postbaseline. Decreases in the number of treatment side effects differed by time and treatment/ ethnic group interactions as did satisfaction with sexual functioning.CONCLUSIONSThis is one of the first tests of a psychoeducational intervention among men with prostate carcinoma and was the first test that included a sufficient number of African‐American men to test by ethnic group. Therefore, replication of these findings is advised. Cancer 2002;94:1854–66. © 2002 American Cancer Society.DOI 10.1002/cncr.10390

show abstract

Section: Dependent Measuresmentioning

confidence: 99%

Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects

Mishel

Belyea

Germino

et al. 2002

Cancer

195

310

View full text Add to dashboard Cite

show abstract

“…• Symptom Distress Scale (85)(86)(87)(88)(89)(90). The Symptom Distress Scale includes 13 items rated on a five-point scale; higher scores reflect more distress.…”

Section: Southwest Oncology Group Instrumentmentioning

confidence: 99%

“…The scale covers 11 areas such as nausea, loss of appetite, insomnia, and pain. Reliability coefficients (coefficient alpha) of J8-.89 were reported (85)(86)(87)(88)(89). Construct validity was demonstrated for the scale in that symptom distress was negatively correlated with a global measure of quality of life (90).…”

Section: Southwest Oncology Group Instrumentmentioning

confidence: 99%

“…Construct validity was demonstrated for the scale in that symptom distress was negatively correlated with a global measure of quality of life (90). McCorkle et al (87,88) found the instrument to be sensitive to changes over time and between treatment groups. In the group receiving office care only, patients with lung cancer reported an increase in symptoms 6 weeks before a similar increase occurred for patients in two groups receiving home-nursing treatment.…”

Section: Southwest Oncology Group Instrumentmentioning

confidence: 99%

See 1 more Smart Citation

Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations

Moinpour

Feigl

Metch

et al. 1989

JNCI Journal of the National Cancer Institute

370

129

View full text Add to dashboard Cite

In this presentation, issues that influenced the development of policies for inclusion of quality of life end points in cer-In this review, we address issues and methods associated with measurement of quality of life in clinical trials and recommend specific instruments appropriate for clinical trials research. Our review was initiated in November 1987 at the request of the Southwest Oncology Group Cancer Control Research Committee. One motivation for the assessment of quality of life was the increased attention to cancer control research, both at the National Cancer Institute and in the Southwest Oncology Group. We circulated a position paper among the leaders of the Southwest Oncology Group recommending how and to what extent quality of life end points should be included in the group's clinical trials. Our recommendations were adopted by the Cancer Control Research Committee in October 1988. The policies we developed for assessing quality of life in selected trials are potentially relevant, with appropriate modifications, to other multi-institution clinical trials.The Southwest Oncology Group was organized in 1956 with the objectives of reducing mortality from cancer and improving care of patients with malignant disease. Participating medical institutions work together to conduct cancer clinical trials that evaluate the efficacy of cancer therapies. In the last 12 months, approximately 4,000 cancer patients were registered in 130 studies; 69% were in randomized comparative phase HI trials.The benefits of a cancer treatment regimen should outweigh its cost in patient suffering (7,2). By adding quality of life end points to the traditional end points of overall survival, disease-free survival, and tumor response, medical researchers can make more informed decisions about risk-benefit trade-offs; for example, two types of survival-quality of life trade-offs can be described. In one case, two treatments are associated with similar survival rates, but one treatment produces more severe toxic effects; in another case, one of two treatments demonstrates a better survival rate but has more severe toxic effects (3). Quality of life data can add to medical knowledge obtained in the conduct of clinical trials; such data do not supplant existing traditional end points, nor do they replace data on toxic effects based on physician reports.Received October 24, 1988; revised January 3, 1989; accepted January 4, 1989. Supported by Public Health Service grant CA-37429 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. Based in part on work completed by Dr. C. M. Moinpour while she was a National Research Service Award postdoctoral fellow Barofsky (4) argued that many clinical trials have paid at least implicit attention to quality of life issues, e.g., the focus of the National Surgical Adjuvant Breast and Bowel Project on the survival time associated with different degrees of surgery. Other trials (5-70) with breast cancer patients address quality of life issues expl...

show abstract

“…However, complications after discharge may go undetected and require readmittance to the hospital and more acute care visits (Britton & Britton, 1984;Jansson, 1985;Rogers et al, 1990;Schwartzberg, 1982). To maintain good patient outcomes while lowering hospital charges, a number of programs of early hospital discharge and home follow-up have been developed for groups of patients at high risk who use a high volume of services (Brooten et al, 1986;McCorkle et al, 1989). Women delivering by unplanned cesarean birth represent such a group.…”

mentioning

confidence: 99%

Early Discharge and Home Care After Unplanned Cesarean Birth: Nursing Care Time

Brooten

Knapp

Borucki³

et al. 1996

Journal of Obstetric, Gynecologic & Neonatal Nursing

View full text Add to dashboard Cite

Objective-This study examined the mean nursing time spent providing discharge planning and home care to women who delivered by unplanned cesarean birth and examined differences in nursing time required by women with and without morbidity.Design-A secondary analysis of nursing time from a randomized trial of transitional care (discharge planning and home follow-up) provided to women after cesarean delivery. Setting-An urban tertiary-care hospital.Patients-The sample (N = 61) of black and white women who had unplanned cesarean births and their full-term newborns was selected randomly. Forty-four percent of the women had experienced pregnancy complications.Interventions-Advanced practice nurses provided discharge planning and 8-week home follow-up consisting of home visits, telephone outreach, and daily telephone availability.Outcome Measure-Nursing time required was dictated by patient need and provider judgment rather than by reimbursement plan. NIH Public AccessAuthor Manuscript J Obstet Gynecol Neonatal Nurs. Author manuscript; available in PMC 2013 June 27.Published in final edited form as: J Obstet Gynecol Neonatal Nurs. 1996 September ; 25(7): 595-600. NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author ManuscriptResults-More than half of the women required more than two home visits; mean home visit time was 1 hour. For women who experienced morbidity mean discharge planning time was 20 minutes more and mean home visit time 40 minutes more.Conclusions-Current health care services that provide one or two 1-hour home visits to childbearing women at high risk may not be meeting the education and resource needs of this group.National strategies to control health care costs have resulted in earlier hospital discharge of many patient groups. Earlier discharge may reduce hospital charges and return patients to their families sooner. However, complications after discharge may go undetected and require readmittance to the hospital and more acute care visits (Britton & Britton, 1984;Jansson, 1985;Rogers et al., 1990;Schwartzberg, 1982). To maintain good patient outcomes while lowering hospital charges, a number of programs of early hospital discharge and home follow-up have been developed for groups of patients at high risk who use a high volume of services (Brooten et al., 1986;McCorkle et al., 1989). Women delivering by unplanned cesarean birth represent such a group.Almost one in four women who give birth in the United States do so by cesarean birth (Taffel, Placek, & Korsary, 1992). The hospital stay after cesarean birth has decreased from a mean of 6.1 days in 1982 to 4.0 days in 1992 (Commission on Professional & Hospital Activities, 1991;. One recent report suggested a 2-day length of stay for women after delivery by cesarean birth, provided they had no complications during pregnancy and delivery and after delivery (Strong, Brown, Brown, & Curry, 1993). Many early discharge programs for high-risk groups have home follow-up services that differ in length, services, and provider (Meissier, 19...

show abstract

A randomized clinical trial of home nursing care for lung cancer patients

Cited by 238 publications

References 20 publications

Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects

Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects

Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations

Early Discharge and Home Care After Unplanned Cesarean Birth: Nursing Care Time

Contact Info

Product

Resources

About